Since transcription of the TMPRSS2 gene is regulated by androgen receptors, their antagonists may be considered as a therapeutic option against COVID-19 due to its role in downregulating TMPRSS2 [72]. The gene discussed is TMPRSS2; the disease is COVID-19.